Moreover, increased serum Chi3L1 levels in SSc were associated with MRSS and lung function, suggesting its relevance to fibrosis and utility as a potential serum biomarker to reflect the extent of fibrosis in SSc. Here, CHI3L1 is linked to systemic sclerosis.